Acurx Pharmaceuticals, Inc. (ACXP) Balance Sheet
ACXP balance sheet, 2025
December 31, 2025 · U.S. dollars$7.7M assets = $2.4M liabilities + $5.3M equity
Both columns are drawn to the same scale: what ACXP owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ACXP financial health
Descriptive bands, not a rating. Fiscal 2025.
ACXP balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $2.5M2019 | $7.7M2025 | +20.3%/yr | |
| Total liabilities | $1.7M2019 | $2.4M2025 | +5.9%/yr | |
| Shareholders’ equity | $819,8542019 | $5.3M2025 | +36.4%/yr | |
| Cash & short-term investments | $2.5M2019 | $7.6M2025 | +20.4%/yr | |
| Working capital | $819,8542019 | $5.3M2025 | +$4.4M | |
| Current ratio | 1.482019 | 3.182025 | +1.70 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ACXP assets
ACXP liabilities and equity
ACXP debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ACXP balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $7.6M | $3.7M | $7.5M | $9.1M | $13.0M | $3.2M | $2.5M |
| Cash & equivalents | $7.6M | $3.7M | $7.5M | $9.1M | $13.0M | $3.2M | $2.5M |
| Receivables | $48,417 | $51,127 | $129,159 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $85,018 | $100,123 | $105,776 | $264,955 | $295,304 | $48,609 | $48,103 |
| Total current assets | $7.7M | $3.9M | $7.7M | $9.4M | $13.3M | $3.2M | $2.5M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $7.7M | $3.9M | $7.7M | $9.4M | $13.3M | $3.2M | $2.5M |
| Liabilities | |||||||
| Accounts payable | — | — | $3,809 | $29,539 | $63,374 | — | $2,304 |
| Short-term debt | — | — | — | — | — | $16,625 | — |
| Total current liabilities | $2.4M | $3.2M | $3.0M | $2.1M | $843,909 | $472,556 | $1.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $49,878 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $2.1M | $0 | $0 | $0 |
| Total liabilities | $2.4M | $3.2M | $3.0M | $2.1M | $843,909 | $522,434 | $1.7M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $2,348 | $17,031 | $14,468 | $11,628 | $10,216 | $16.5M | $10.0M |
| Retained earnings (deficit) | −$75.3M | −$67.3M | −$53.2M | −$38.6M | −$26.5M | −$13.8M | −$9.2M |
| Accumulated other comprehensive income | — | — | — | −$38.6M | −$26.5M | −$13.8M | −$9.2M |
| Total shareholders' equity | $5.3M | $615,121 | $4.7M | $7.3M | $12.4M | $2.7M | $819,854 |
| Key figures | |||||||
| Total debt | — | — | — | — | — | $66,503 | — |
| Net cash (debt) | — | — | — | — | — | $3.1M | — |
| Working capital | $5.3M | $615,121 | $4.7M | $7.3M | $12.4M | $2.8M | $819,854 |
| Tangible book value | $5.3M | $615,121 | $4.7M | $7.3M | $12.4M | $2.7M | $819,854 |
| Book value per share | $3.51 | — | — | — | — | — | — |
| Shares outstanding | 1.5M | — | — | — | — | — | — |
| Current ratio | 3.18 | 1.19 | 2.53 | 4.55 | 15.71 | 6.82 | 1.48 |
| Quick ratio | 3.14 | 1.16 | 2.50 | 4.42 | 15.36 | 6.72 | 1.45 |
| Debt / equity | — | — | — | — | — | 0.02 | — |
| Equity / assets | 68.5% | 15.9% | 60.5% | 78.0% | 93.6% | 83.8% | 32.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $10.7M | $9.3M | $7.6M | $5.9M | $6.1M | $4.6M | $3.7M | $5.8M | $6.4M | $8.9M | $7.5M | $7.1M |
| Cash & equivalents | $10.7M | $9.3M | $7.6M | $5.9M | $6.1M | $4.6M | $3.7M | $5.8M | $6.4M | $8.9M | $7.5M | $7.1M |
| Short-term investments | — | — | — | — | — | — | — | $5.76B | — | — | — | — |
| Receivables | $95,307 | $56,313 | $48,417 | $40,208 | $40,208 | $0 | $51,127 | $97,373 | $51,127 | $0 | $129,159 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $233,084 | $228,826 | $85,018 | $158,201 | $53,522 | $161,574 | $100,123 | $122,822 | $168,407 | $187,908 | $105,776 | $105,722 |
| Total current assets | $11.0M | $9.5M | $7.7M | $6.1M | $6.2M | $4.8M | $3.9M | $6.0M | $6.6M | $9.1M | $7.7M | $7.2M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $11.0M | $9.5M | $7.7M | $6.1M | $6.2M | $4.8M | $3.9M | $6.0M | $6.6M | $9.1M | $7.7M | $7.2M |
| Liabilities | ||||||||||||
| Accounts payable | $3,825 | — | — | — | — | — | — | $19,097 | $10,134 | $9,202 | $3,809 | $11,722 |
| Total current liabilities | $2.8M | $2.5M | $2.4M | $2.5M | $2.6M | $2.5M | $3.2M | $3.3M | $3.2M | $3.1M | $3.0M | $3.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $2.8M | $2.5M | $2.4M | $2.5M | $2.6M | $2.5M | $3.2M | $3.3M | $3.2M | $3.1M | $3.0M | $3.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $4,683 | $3,389 | $2,348 | $1,800 | $1,470 | $22,398 | $17,031 | $16,770 | $15,996 | $15,757 | $14,468 | $13,005 |
| Retained earnings (deficit) | −$79.2M | −$77.0M | −$75.3M | −$73.7M | −$71.7M | −$69.5M | −$67.3M | −$64.5M | −$61.7M | −$57.6M | −$53.2M | −$48.1M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | $0 | — | — | — |
| Total shareholders' equity | $8.2M | $7.0M | $5.3M | $3.6M | $3.6M | $2.3M | $615,121 | $2.7M | $3.4M | $6.0M | $4.7M | $3.9M |
| Key figures | ||||||||||||
| Working capital | $8.2M | $7.0M | $5.3M | $3.6M | $3.6M | $2.3M | $615,121 | $2.7M | $3.4M | $6.0M | $4.7M | $3.9M |
| Tangible book value | $8.2M | $7.0M | $5.3M | $3.6M | $3.6M | $2.3M | $615,121 | $2.7M | $3.4M | $6.0M | $4.7M | $3.9M |
| Book value per share | $1.91 | $4.68 | $3.51 | $2.24 | $3.00 | — | — | — | — | — | — | — |
| Shares outstanding | 4.3M | 1.5M | 1.5M | 1.6M | 1.2M | — | — | — | — | — | — | — |
| Current ratio | 3.88 | 3.78 | 3.18 | 2.47 | 2.38 | 1.93 | 1.19 | 1.80 | 2.09 | 2.93 | 2.53 | 2.22 |
| Quick ratio | 3.80 | 3.68 | 3.14 | 2.41 | 2.36 | 1.86 | 1.16 | 1.77 | 2.03 | 2.87 | 2.50 | 2.19 |
| Equity / assets | 74.2% | 73.5% | 68.5% | 59.6% | 57.9% | 48.1% | 15.9% | 44.5% | 52.1% | 65.9% | 60.5% | 55.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.
ACXP financial position
At the end of fiscal 2025 (December 31, 2025), Acurx Pharmaceuticals had total assets of $7.7 million (up 99.3% from a year earlier), total liabilities of $2.4 million and shareholders' equity of $5.3 million. Its current ratio was 3.18. In the latest quarter (ended June 30, 2026) total assets were $11.0 million and equity $8.2 million.
Related: ACXP income statement, ACXP cash flow statement, ACXP key metrics. See the ACXP stock overview for the latest quote and news.
ACXP balance sheet FAQ
What are Acurx Pharmaceuticals's total assets?
Acurx Pharmaceuticals reported total assets of $7.7 million at the end of fiscal 2025 (December 31, 2025), compared with $3.9 million a year earlier.
How much cash does Acurx Pharmaceuticals have?
Acurx Pharmaceuticals held $7.6 million in cash and short-term investments at the end of fiscal 2025.
What is Acurx Pharmaceuticals's book value?
Acurx Pharmaceuticals's shareholders' equity (book value) was $5.3 million at the end of fiscal 2025, or $3.51 per share.
What is Acurx Pharmaceuticals's current ratio?
Acurx Pharmaceuticals had current assets of $7.7 million and current liabilities of $2.4 million, a current ratio of 3.18 (it can cover its short-term obligations).